Public signalCompany raiseAuto-indexed · Unverified

Phio Pharmaceuticals Corp. raised $208K

Phio Pharmaceuticals Corp.· KING OF PRUSSIA, US· Biotechnology· Filed Jan 28, 2025

Phio Pharmaceuticals Corp. reported raising capital. Based in KING OF PRUSSIA, PENNSYLVANIA, US. First sale reported 2025-01-15. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$208,334
Confidence90%
Raised
$208,334
Investors
4
Jurisdiction
DELAWARE

On the record

Location
KING OF PRUSSIA, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$208,334
Target amount
$5.0M
Filing date
Jan 28, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Biotechnology
Number of investors
4
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$5.0M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 208,334 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Jan 28, 2025. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnology$100K – $1MCompany Raise

Are you associated with Phio Pharmaceuticals Corp.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record